Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
25
ERMAY Quote, Financials, Valuation and Earnings
Last price:
$5.45
Seasonality move
:
-9.4%
Day range:
$5.45 - $5.51
52-week range:
$4.44 - $12.21
Dividend yield:
2.99%
P/E ratio:
105.33x
P/S ratio:
0.50x
P/B ratio:
1.04x
Volume:
5.8K
Avg. volume:
740
1-year change:
-50.66%
Market cap:
$1.6B
Revenue:
$3.2B
EPS (TTM):
$0.05
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Eramet SA has -- downside to fair value with a price target of -- per share.
ERMAY vs. S&P 500
-
Over the past 5 trading days, Eramet SA has underperformed the S&P 500 by -4.43% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Eramet SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Eramet SA revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Eramet SA reported revenues of --.
Earnings Growth
-
Eramet SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Eramet SA reported earnings per share of --.
Enterprise value:
3.6B
EV / Invested capital:
--
Price / LTM sales:
0.50x
EV / EBIT:
15.58x
EV / Revenue:
1.14x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.58x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
15.58x
Gross Profit (TTM):
$1.8B
Return On Assets:
0.21%
Net Income Margin (TTM):
0.46%
Return On Equity:
-1.35%
Return On Invested Capital:
0.31%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2012-12-31 | 2013-12-31 | |
| Income Statement | ||||||
| Revenue | $5.1B | $4.5B | $4.1B | $2.3B | $2.2B | |
| Gross Profit | $1B | $530.3M | $169M | $445.2M | $339.6M | |
| Operating Income | $622.2M | $106.8M | -$236.7M | $13.3M | -$705.4M | |
| EBITDA | $930.9M | $452.6M | $199.9M | $190.8M | $71.5M | |
| Diluted EPS | $1.04 | $0.04 | -$1.91 | -$0.06 | -$1.77 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.2B | $3.5B | $4.3B | $3.3B | $2.5B | |
| Total Assets | $7.9B | $7.1B | $7.7B | $6.9B | $6.7B | |
| Current Liabilities | $1.9B | $2.4B | $2.7B | $1.9B | $1.5B | |
| Total Liabilities | $6.7B | $5.6B | $5.3B | $4.7B | $4.5B | |
| Total Equity | $1.2B | $1.5B | $2.4B | $2.2B | $2.2B | |
| Total Debt | $3.8B | $2.3B | $2.1B | $2.4B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-06-30 | 2012-06-30 | 2013-06-30 | 2012-06-30 | 2013-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $974.9M | $507.4M | $275.4M | $63.4M | $84.7M | |
| Cash From Investing | -$487.3M | -$1B | -$399.1M | -$395.6M | -$189M | |
| Cash From Financing | -$215M | -$54.1M | $92.5M | $5M | $113.4M | |
| Free Cash Flow | $704.8M | $115.8M | -$441.1M | -$316M | -$269.8M | |
ERMAY
Sector
Market Cap
$1.6B
$18.1M
Price % of 52-Week High
44.64%
62.87%
Dividend Yield
2.99%
0%
Shareholder Yield
2.12%
1.07%
1-Year Price Total Return
-50.66%
-17.33%
Beta (5-Year)
1.197
0.779
Dividend yield:
2.99%
Annualized payout:
$0.16
Payout ratio:
319.74%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.71
200-day SMA
Sell
Level
$6.13
Bollinger Bands (100)
Sell
Level
5.27 - 6.11
Chaikin Money Flow
Buy
Level
191.5K
20-day SMA
Sell
Level
$5.63
Relative Strength Index (RSI14)
Sell
Level
43.44
ADX Line
Sell
Level
16.73
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$5.63
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
450.2K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.327)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.1917)
Sell
Piotroski F Score
(Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Eramet SA is a French mining and metallurgical company focused on the extraction, production, and sale of alloying metals, principally Manganese, Nickel, Mineral Sands, and Lithium. The company is also engaged in the production and transformation of alloys. Manganese constitutes nearly half of Eramet's revenue, followed by Nickel. Geographically, the majority of the company's revenue is generated from Asia and the rest from Europe, North America, France, and other regions.
Stock Forecast FAQ
In the current month, ERMAY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ERMAY average analyst price target in the past 3 months is --.
-
Where Will Eramet SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Eramet SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Eramet SA?
Analysts are divided on their view about Eramet SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Eramet SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Eramet SA's Price Target?
The price target for Eramet SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ERMAY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Eramet SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ERMAY?
You can purchase shares of Eramet SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Eramet SA shares.
-
What Is The Eramet SA Share Price Today?
Eramet SA was last trading at $5.45 per share. This represents the most recent stock quote for Eramet SA. Yesterday, Eramet SA closed at $5.45 per share.
-
How To Buy Eramet SA Stock Online?
In order to purchase Eramet SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 1.56% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 1.32% over the past day.
